New Lantern
-56%
est. 2Y upside i
New Lantern accelerates radiology with cloud & AI powered medical image analysis. We're in stealth, and we are actively hiring software engineers. If you're curious and interested in architecting the future of medical imaging & disease diagnosis, we're hiring.
Rank
#3347
Sector
Healthcare AI, Medical Imaging, SaaS
Est. Liquidity
~7Y
Data Quality
Data: LowEquity upside is highly uncertain and likely negative given the steep entry multiple (54.5x revenue) vs. public comps.
Last updated: July 19, 2026
Multiple holds at 30x revenue (AI hype sustained; IPO window opens). Exit value $84M, but 20pp dilution and 38% preference overhang limit net upside to ~20%.
Multiple converges to public comp range of 10-15x forward revenue. Exit value ~$33.6M, common stock faces ~64% loss after dilution and preference.
Multiple compresses to 5x, exit value $14M below $23M liquidation preference; common stock worthless, -100% loss.
Preference Stack Risk
severeFunding Intensity
38%Total preferred stock liquidation preference of $23M represents 38% of the assumed $60M entry valuation, significantly diluting common stock value.
Dilution Risk
moderateWith $23M funding and $1.1M revenue, runway is ~4.5 years; a future raise is possible but not imminent within 24 months.
Secondary Liquidity
noneNo secondary market activity detected; equity is illiquid until a liquidity event.
Engineering — 4 roles
- Backend Software Engineer · San Francisco
- Frontend Software Engineer · San Francisco
- Software Engineer, DICOM infrastructure · San Francisco
- +1 more →
Operations — 4 roles
- Customer & Implementations Specialist · San Francisco
- Integration Engineer, DICOM · San Francisco
- Project Manager · San Francisco
- +1 more →
Sales — 1 role
- Sales Operations Analyst · San Francisco
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on New Lantern's data — designed to show you've done your homework.
- 1
“How does your platform differentiate from PACS-integrated AI solutions offered by large EHR vendors?”
- 2
“What is the current annual recurring revenue (ARR) growth rate and churn?”
- 3
“What is the company's strategy to achieve liquidity (IPO or acquisition) given the $23M preference stack?”
Community
Valuation Sentiment
Our model estimates -56% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.